Sugi Predict

Sugi Predict / Compounds / SCHEMBL220134

SCHEMBL220134

SCHEMBL220134

CC(=O)Oc1ccc2c(CC(=O)O)cc(=O)oc2c1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 6/20 0.78
▸ LCK P06239 2/20 0.78
▸ ALDH1A1 P00352 5/20 0.67
▸ GAA P10253 4/20 0.67
▸ GLA P06280 3/20 0.67
▸ AKR1B1 P15121 2/20 0.64
▸ FYN P06241 1/20 0.64
▸ GRB2 P62993 1/20 0.64
▸ HPGD P15428 2/20 0.61
▸ POLB P06746 2/20 0.56
▸ CA12 O43570 2/20 0.56
▸ CA9 Q16790 2/20 0.56
▸ TDP1 Q9NUW8 1/20 0.56
▸ MCL1 Q07820 1/20 0.56
▸ KMT2A Q03164 2/20 0.55
▸ MEN1 O00255 1/20 0.53
▸ PKM P14618 1/20 0.53
▸ L3MBTL1 Q9Y468 1/20 0.53
▸ MAPT P10636 1/20 0.52
▸ CYP2D6 P10635 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13839168 0.88 KDM4E (0.65) KDM4ELCKALDH1A1GAAGLA
SCHEMBL246218 0.88 KDM4E (1.00) KDM4ELCKALDH1A1AKR1B1FYN
SCHEMBL29397959 0.88 KDM4E (1.00) KDM4ELCKALDH1A1AKR1B1FYN
SCHEMBL68231 0.85 KDM4E (0.68) KDM4ELCKALDH1A1GAAGLA
SCHEMBL20767988 0.85 KDM4E (0.68) KDM4ELCKALDH1A1GAAGLA
SCHEMBL24025684 0.85 KDM4E (0.68) KDM4ELCKALDH1A1GAAGLA
SCHEMBL8863327 0.83 KDM4E (0.65) KDM4ELCKALDH1A1GAAGLA
SCHEMBL15963915 0.82 LCK (0.70) KDM4ELCKALDH1A1AKR1B1FYN
SCHEMBL13609430 0.82 KDM4E (0.64) KDM4ELCKALDH1A1GAAGLA
SCHEMBL220020 0.81 KDM4E (0.58) KDM4ELCKALDH1A1GAAGLA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9790536-B2 Methods for assaying alpha-L-iduronidase enzymatic activity UNIVERSITY OF WASHINGTON (US) 2017-10-17 — — US disclosed
US-20170233426-A1 METHOD FOR 2-SULFATION OF GLYCOSIDES UNIVERSITY OF WASHINGTON (US) 2017-08-17 — — US disclosed
US-20170233426-A1 METHOD FOR 2-SULFATION OF GLYCOSIDES UNIVERSITY OF WASHINGTON (US) 2017-08-17 — — US disclosed
US-9481701-B2 Method for 2-sulfation of glycosides UNIVERSITY OF WASHINGTON (US) 2016-11-01 — — US disclosed
US-9481701-B2 Method for 2-sulfation of glycosides UNIVERSITY OF WASHINGTON (US) 2016-11-01 — — US disclosed
US-20150353985-A1 METHODS FOR ASSAYING ALPHA-L-IDURONIDASE ENZYMATIC ACTIVITY UNIVERSITY OF WASHINGTON (US) 2015-12-10 — — US disclosed
US-20150158900-A1 METHOD FOR 2-SULFATION OF GLYCOSIDES UNIVERSITY OF WASHINGTON (US) 2015-06-11 — — US disclosed
US-20150158900-A1 METHOD FOR 2-SULFATION OF GLYCOSIDES UNIVERSITY OF WASHINGTON (US) 2015-06-11 — — US disclosed
US-9012663-B2 Methods for assaying α-L-iduronidase enzymatic activity UNIVERSITY OF WASHINGTON (US) 2015-04-21 — — US disclosed
US-8802833-B2 Method for 2-sulfation of glycosides UNIVERSITY OF WASHINGTON (US) 2014-08-12 — — US disclosed
US-20110288281-A1 METHOD FOR 2-SULFATION OF GLYCOSIDES UNIVERSITY OF WASHINGTON (US) 2011-11-24 — — US disclosed
US-20110288281-A1 METHOD FOR 2-SULFATION OF GLYCOSIDES UNIVERSITY OF WASHINGTON (US) 2011-11-24 — — US disclosed
EP-2385950-A2 METHOD FOR 2-SULFATION OF GLYCOSIDES University Of Washington (US) 2011-11-16 — — EP disclosed
US-8039496-B2 Therapeutic compounds ALLERGAN, INC. (US) 2011-10-18 — — US disclosed
US-20100209951-A1 METHODS FOR ASSAYING ALPHA-L-IDURONIDASE ENZYMATIC ACTIVITY UNIVERSITY OF WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION (US) 2010-08-19 — — US disclosed
WO-2010081163-A2 METHOD FOR 2-SULFATION OF GLYCOSIDES UNIVERSITY OF WASHINGTON (US) 2010-07-15 — — WO disclosed
EP-2191006-A1 METHODS FOR ASSAYING ALPHA-L-IDURONIDASE ENZYMATIC ACTIVITY University of Washington (US) 2010-06-02 — — EP disclosed
WO-2009026252-A1 METHODS FOR ASSAYING ALPHA-L-IDURONIDASE ENZYMATIC ACTIVITY UNIVERSITY OF WASHINGTON (US) 2009-02-26 — — WO disclosed
US-7449558-B2 Site-specific labelling of proteins NATIONAL UNIVERSITY OF SINGAPORE (SG) 2008-11-11 — — US disclosed
US-20050158804-A1 Site-specific labelling of proteins NATIONAL UNIVERSITY OF SINGAPORE (SG) 2005-07-21 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150353985-A1 METHODS FOR ASSAYING ALPHA-L-IDURONIDASE ENZYMATIC ACTIVITY IDUA, GAA, ENGASE KDM4E 4238/4885LCK 4717/4885ALDH1A1 367/4885
US-20100209951-A1 METHODS FOR ASSAYING ALPHA-L-IDURONIDASE ENZYMATIC ACTIVITY IDUA, GAA, ENGASE KDM4E 4238/4885LCK 4717/4885ALDH1A1 367/4885
US-20110288281-A1 METHOD FOR 2-SULFATION OF GLYCOSIDES UGT8, STS, ST6GAL1 KDM4E 4025/4885LCK 4311/4885ALDH1A1 1844/4885
US-20150158900-A1 METHOD FOR 2-SULFATION OF GLYCOSIDES UGT8, STS, ST6GAL1 KDM4E 4025/4885LCK 4311/4885ALDH1A1 1844/4885
US-20170233426-A1 METHOD FOR 2-SULFATION OF GLYCOSIDES UGT8, STS, ST6GAL1 KDM4E 4025/4885LCK 4311/4885ALDH1A1 1844/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.